These include the production of estrogen receptor-positive and progesterone receptor-positive (ER+PR+) and ER−PR− tumours from mouse basal and luminal cells engineered separately to express PIK3CA(H1047R), thereby creating models that appear to mirror analogous phenotypes of human breast cancer64, 65. This evidence concerns the gene PGR and neoplasm.